Slightly off topic - has anybody seen any data (I know, I know) on the percentage of COVID-after-vaccine cases for the mRNA vs. the non-mRNA types?
They are all different. It is really difficult to compare trial results from 2 different ‘drugs’ without running a head to head trial. But data out of the UK and Israel seems to indicate the Pfizer and the AstraZeneca (AZ not available in the US) don’t have lasting immunity effects. Some have said the AZ vaccine is the least effective and it may be considering the UK is 70% vaccinated and still doing various forms of lock down and isolation (they have a tracking app and send you an alert if it appears you were near someone infected, requiring you go to quarantine). Some have said the J&J vaccine is the least effective in the USA, but J&J claims theirs is very strong against the Delta variant. Israel says the Pfizer is only 39% effective against Delta but prevents about 90% of serious illness and hospitalization (which means, 10% of vaccinated will get very sick even after PFE vaccine if infected with Delta).
Bottom line, I don’t think we will ever know. After the fact we can look back and see the relative risks and rewards but it would just be a post hoc study and not reliable. But these “breakthrough cases” are more and more prominent suggesting the immunity doesn’t last and/or that it may be causing ADE or that the virus mutations, in Darwinist fashion, circumvent the vaccines. Now in the USA we have the Colombian variant on the rise.